MingSight inks Chinese JV to progress oral diabetic retinopathy drug
This article was originally published in Scrip
Executive Summary
The private US company MingSight Pharmaceuticals has formed a joint venture with a Chinese ophthalmic firm for the development and commercialisation in China of an oral molecule for diabetes -related retinopathy.